• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Sjoerd D. Kuiken, Guido N. J. Tytgat, Guy E. E. Boeckxstaens
  • Medicine
  • Clinical gastroenterology and hepatology : the…
  • 2003 (First Published: 1 May 2003)
  • BACKGROUND & AIMS Although widely prescribed, the evidence for the use of antidepressants for the treatment of irritable bowel syndrome (IBS) is limited. In this study, we hypothesized thatContinue Reading
  • U K Coblijn, Amin B. Goucham, Sjoerd M. Lagarde, Sjoerd D. Kuiken, Bart A. van Wagensveld
  • Medicine
  • Obesity Surgery
  • 2013 (First Published: 1 February 2014)
  • Laparoscopic Roux-en-Y gastric bypass (LRYGB) is the gold standard in bariatric surgery. A long-term complication can be marginal ulceration (MU) at the gastrojejunostomy. The mechanism ofContinue Reading
  • Sjoerd D. Kuiken, Robert Lindeboom, Guido N. J. Tytgat, Guy E. E. Boeckxstaens
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2005 (First Published: 1 July 2005)
  • BACKGROUND Visceral hypersensitivity is considered an important pathophysiological mechanism in irritable bowel syndrome, yet its relationship to symptoms is unclear. AIM To detect possibleContinue Reading
  • Sjoerd D. Kuiken, Guido N. J. Tytgat, Guy E. E. Boeckxstaens
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2005 (First Published: 1 March 2005)
  • At present, the concept of visceral hypersensitivity provides the leading hypothesis regarding the generation of symptoms in functional gastrointestinal disorders. This paper discusses the currentContinue Reading
  • Tamira K. Klooker, Sjoerd D. Kuiken, Aaltje Lei, Guy E. E. Boeckxstaens
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2007 (First Published: 7 June 2007)
  • BACKGROUND Acute administration of octreotide reduces visceral perception and therefore has been suggested as potential treatment for irritable bowel syndrome. Whether prolonged treatment withContinue Reading